← All patents

US11466017B2

Heterocyclic inhibitors of PTPN11

University of Texas System

Abstract

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Philip Jones
Priority date
March 10, 2011
Filing date
August 10, 2020
Grant date
October 11, 2022
Publication date
October 11, 2022
Language
en
Metadata fetched
August 29, 2026 00:30